Bristol Myers Squibb Announces Dividend
Bristol Myers Squibb (NYSE: BMY) has announced its latest dividend declarations. The company's Board of Directors has declared a quarterly dividend of $0.62 per share on the $0.10 par value common stock, payable on May 1, 2025, to stockholders of record as of April 4, 2025.
Additionally, the Board has declared a quarterly dividend of $0.50 per share on the company's $2.00 convertible preferred stock, which will be payable on June 2, 2025, to stockholders of record as of May 6, 2025.
Bristol Myers Squibb (NYSE: BMY) ha annunciato le sue ultime dichiarazioni sui dividendi. Il Consiglio di Amministrazione della società ha dichiarato un dividendo trimestrale di $0,62 per azione sulle azioni ordinarie con valore nominale di $0,10, pagabile il 1° maggio 2025, agli azionisti registrati al 4 aprile 2025.
Inoltre, il Consiglio ha dichiarato un dividendo trimestrale di $0,50 per azione sulle azioni privilegiate convertibili della società, che sarà pagabile il 2 giugno 2025, agli azionisti registrati al 6 maggio 2025.
Bristol Myers Squibb (NYSE: BMY) ha anunciado sus últimas declaraciones de dividendos. La Junta Directiva de la compañía ha declarado un dividendo trimestral de $0.62 por acción sobre las acciones ordinarias con un valor nominal de $0.10, que se pagará el 1 de mayo de 2025, a los accionistas registrados hasta el 4 de abril de 2025.
Además, la Junta ha declarado un dividendo trimestral de $0.50 por acción sobre las acciones preferentes convertibles de la compañía, que se pagará el 2 de junio de 2025, a los accionistas registrados hasta el 6 de mayo de 2025.
Bristol Myers Squibb (NYSE: BMY)는 최신 배당금 발표를 했습니다. 회사의 이사회는 액면가 $0.10의 보통주에 대해 주당 $0.62의 분기 배당금을 선언했으며, 이는 2025년 5월 1일에 지급되고 2025년 4월 4일 기준 주주에게 지급됩니다.
또한 이사회는 회사의 $2.00 전환 우선주에 대해 주당 $0.50의 분기 배당금을 선언했으며, 이는 2025년 6월 2일에 지급되고 2025년 5월 6일 기준 주주에게 지급됩니다.
Bristol Myers Squibb (NYSE: BMY) a annoncé ses dernières déclarations de dividendes. Le Conseil d'Administration de la société a déclaré un dividende trimestriel de 0,62 $ par action sur les actions ordinaires d'une valeur nominale de 0,10 $, payable le 1er mai 2025, aux actionnaires inscrits au 4 avril 2025.
De plus, le Conseil a déclaré un dividende trimestriel de 0,50 $ par action sur les actions privilégiées convertibles de la société, qui sera payable le 2 juin 2025, aux actionnaires inscrits au 6 mai 2025.
Bristol Myers Squibb (NYSE: BMY) hat seine neuesten Dividendenankündigungen bekannt gegeben. Der Vorstand des Unternehmens hat eine vierteljährliche Dividende von 0,62 $ pro Aktie auf die Stammaktien mit einem Nennwert von 0,10 $ erklärt, die am 1. Mai 2025 an die Aktionäre ausgezahlt wird, die am 4. April 2025 im Aktienregister stehen.
Darüber hinaus hat der Vorstand eine vierteljährliche Dividende von 0,50 $ pro Aktie auf die wandelbaren Vorzugsaktien des Unternehmens erklärt, die am 2. Juni 2025 an die Aktionäre ausgezahlt wird, die am 6. Mai 2025 im Aktienregister stehen.
- Regular dividend payments indicate financial stability
- Consistent cash returns to shareholders
- None.
In addition, the Board of Directors has declared a quarterly dividend of
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20250303907522/en/
For more information, contact:
Media Relations:
media@bms.com
Investor Relations:
investor.relations@bms.com
Source: Bristol Myers Squibb
FAQ
What is the quarterly dividend amount for BMY common stock in 2025?
When is BMY's next dividend payment date for common stockholders?
What is BMY's quarterly dividend for preferred stockholders?
What is the record date for BMY's preferred stock dividend?
